Isbn: 9783030880224 - management of the breast and axilla in the neoadjuvant setting (11 risultati)

Perfeziona la tua ricerca

  • Libri (11)

  • Nuovo (11)

a

Fascia di prezzo personalizzata (EUR)

a

    • Lingua: Inglese

      Editore: Springer, 2022

      3030880222 / 9783030880224

      • Brossura

      Da: Ria Christie Collections, Uxbridge, Regno UnitoRia Christie Collections

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 116,14

      EUR 13,14 spedizione 
      Spedito da Regno Unito a U.S.A.

      Quantità: Più di 20 disponibili

      Condizione: New. In English.

    • Lingua: Inglese

      Editore: Springer, 2022

      3030880222 / 9783030880224

      • Brossura

      Da: Books Puddle, New York, NY, U.S.A.Books Puddle

      Venditore con 4 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 160,23

      EUR 3,48 spedizione 
      Spedito in U.S.A.

      Quantità: 4 disponibili

      Condizione: New.

    • Altre immagini

      Lingua: Inglese

      Editore: Springer, 2022

      3030880222 / 9783030880224

      • Brossura

      Da: preigu, Osnabrück, Germaniapreigu

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 104,25

      EUR 70,00 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: 5 disponibili

      Taschenbuch. Condizione: Neu. Management of the Breast and Axilla in the Neoadjuvant Setting | Atilla Soran (u. a.) | Taschenbuch | xi | Englisch | 2022 | Springer | EAN 9783030880224 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

    • Lingua: Inglese

      Editore: Springer, 2022

      3030880222 / 9783030880224

      • Brossura

      Da: Revaluation Books, Exeter, Regno UnitoRevaluation Books

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 168,07

      EUR 14,55 spedizione 
      Spedito da Regno Unito a U.S.A.

      Quantità: 2 disponibili

      Paperback. Condizione: Brand New. 388 pages. 9.25x6.10x1.02 inches. In Stock.

    • Lingua: Inglese

      Editore: Springer, 2022

      3030880222 / 9783030880224

      • Brossura
      • Print on Demand

      Da: Brook Bookstore On Demand, Napoli, NA, ItaliaBrook Bookstore On Demand

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 94,25

      EUR 6,80 spedizione 
      Spedito da Italia a U.S.A.

      Quantità: Più di 20 disponibili

      Condizione: new. Questo è un articolo print on demand.

    • Lingua: Inglese

      Editore: Springer International Publishing Dez 2022, 2022

      3030880222 / 9783030880224

      • Brossura
      • Print on Demand

      Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 117,69

      EUR 23,00 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: 2 disponibili

      Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Over the last several decades breast cancer management has made great strides in the improvement of oncologic treatment outcomes, particularly so in patients with early stage disease. While wide-spread access to screening resulting in early detection is undoubtedly to be credited for this trend, at the same time, the management of breast cancer has evolved to be an intricate multidisciplinary collaboration between breast imagers, surgeons, medical oncologists and radiation oncologist. As a result, with better mutual understanding of multidisplinary goals and challenges, the treatment strategies have become more individualized, with a great emphasis being placed on the intrinsic disease biology. Furthermore, the indications for neoadjuvant systemic therapy have significantly broadened, with a substantial number of patients with early stage breast cancer being able to take advantage of this strategy to decrease the extent of breast surgery they would undergo at its completion. As such, the management of the axilla in these patients has presented with new challenges as well as with new opportunities to scale down on the extent of local therapy and, consequently, its toxicity.This text will provide a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians (surgeons, medical oncologists, radiation oncologists) and researchers with an interest in breast cancer. The book will review novel and evoling strategies in neoadjuvant systemic therapy forn early stage breast cancer, provide new perspectives about appropriate axillary imaging in anticipation of neoadjuvant systemic therapy, and describe new data on innovative surgical techniques and Radiation Oncology concepts designed to deescalate the extent and toxicity of local therapy while insuring oncologic safety. Several landmark clinical trials have been published in the last few years and will be placed in context with respect to current management. Integration of novel diagnostic and interventional breast imaging, local therapy (surgery and radiation) with contemporary systemic therapy will also be discussed.This text will serve as a very useful resource for physicians and researchers dealing with, and interested in, this challenging field. It will provide a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts. All chapters will be written by experts in their fields and will include the most up to date scientific and clinical information. 392 pp. Englisch.

    • Lingua: Inglese

      Editore: Springer, Berlin|Springer International Publishing|Springer, 2022

      3030880222 / 9783030880224

      • Brossura
      • Print on Demand

      Da: moluna, Greven, Germaniamoluna

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 98,54

      EUR 48,99 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: Più di 20 disponibili

      Kartoniert / Broschiert. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Over the last several decades breast cancer management has made great strides in the improvement of oncologic treatment outcomes, particularly so in patients with early stage disease. While wide-spread access to screening resulting in early detection is und.

    • Lingua: Inglese

      Editore: Springer, 2022

      3030880222 / 9783030880224

      • Brossura
      • Print on Demand

      Da: Majestic Books, Hounslow, Regno UnitoMajestic Books

      Venditore con 4 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 164,26

      EUR 7,57 spedizione 
      Spedito da Regno Unito a U.S.A.

      Quantità: 4 disponibili

      Condizione: New. Print on Demand.

    • Lingua: Inglese

      Editore: Springer, 2022

      3030880222 / 9783030880224

      • Brossura
      • Print on Demand

      Da: Biblios, frankfurt am main, HESSE, GermaniaBiblios

      Venditore con 4 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 166,21

      EUR 9,95 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: 4 disponibili

      Condizione: New. PRINT ON DEMAND.

    • Lingua: Inglese

      Editore: Springer, Springer Dez 2022, 2022

      3030880222 / 9783030880224

      • Brossura
      • Print on Demand

      Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 117,69

      EUR 60,00 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: 1 disponibili

      Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Over the last several decades breast cancer management has made great strides in the improvement of oncologic treatment outcomes, particularly so in patients with early stage disease. While wide-spread access to screening resulting in early detection is undoubtedly to be credited for this trend, at the same time, the management of breast cancer has evolved to be an intricate multidisciplinary collaboration between breast imagers, surgeons, medical oncologists and radiation oncologist. As a result, with better mutual understanding of multidisplinary goals and challenges, the treatment strategies have become more individualized, with a great emphasis being placed on the intrinsic disease biology. Furthermore, the indications for neoadjuvant systemic therapy have significantly broadened, with a substantial number of patients with early stage breast cancer being able to take advantage of this strategy to decrease the extent of breast surgery they would undergo at its completion.As such, the management of the axilla in these patients has presented with new challenges as well as with new opportunities to scale down on the extent of local therapy and, consequently, its toxicity.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 392 pp. Englisch.

    • Lingua: Inglese

      Editore: Palgrave Macmillan, 2022

      3030880222 / 9783030880224

      • Brossura
      • Print on Demand

      Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH

      Venditore con 5 stelle
      Contatta il venditore

      Condizione: Nuovo

      EUR 166,33

      EUR 30,50 spedizione 
      Spedito da Germania a U.S.A.

      Quantità: 1 disponibili

      Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Over the last several decades breast cancer management has made great strides in the improvement of oncologic treatment outcomes, particularly so in patients with early stage disease. While wide-spread access to screening resulting in early detection is undoubtedly to be credited for this trend, at the same time, the management of breast cancer has evolved to be an intricate multidisciplinary collaboration between breast imagers, surgeons, medical oncologists and radiation oncologist. As a result, with better mutual understanding of multidisplinary goals and challenges, the treatment strategies have become more individualized, with a great emphasis being placed on the intrinsic disease biology. Furthermore, the indications for neoadjuvant systemic therapy have significantly broadened, with a substantial number of patients with early stage breast cancer being able to take advantage of this strategy to decrease the extent of breast surgery they would undergo at its completion.As such, the management of the axilla in these patients has presented with new challenges as well as with new opportunities to scale down on the extent of local therapy and, consequently, its toxicity.This text will provide a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians (surgeons, medical oncologists, radiation oncologists) and researchers with an interest in breast cancer. The book will review novel and evoling strategies in neoadjuvant systemic therapy forn early stage breast cancer, provide new perspectives about appropriate axillary imaging in anticipation of neoadjuvant systemic therapy, and describe new data on innovative surgical techniques and Radiation Oncology concepts designed to deescalate the extent and toxicity of local therapy while insuring oncologic safety. Several landmark clinical trials have been published in the last few years and will be placed in context with respect to current management. Integration of novel diagnostic and interventional breast imaging, local therapy (surgery and radiation) with contemporary systemic therapy will also be discussed.This text will serve as a very useful resource for physicians and researchers dealing with, and interested in, this challenging field. It will provide a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts. All chapters will be written by experts in their fields and will include the most up to date scientific and clinical information.